5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate

5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate 구조식 이미지
카스 번호:
상품명:
5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate
동의어(영문):
LY 2228820-d9;5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate
CBNumber:
CB42622774
분자식:
C26H28D9FN6O6S2
포뮬러 무게:
621.792439202
MOL 파일:
Mol file

5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate 속성

안전

5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate C화학적 특성, 용도, 생산

용도

Laballed LY2228820, a novel and potent p38MAPK inhibitor with potent antiinflammatory activity. LY2228820 significantly inhibited phosphorylation of MAPKAPK2 and/or HSP27, down stream targets of p38MAPK, in both multiple myeloma (MM) cell lines and LT-BMSCs. LY2228820 is a potential candidate to improve MM patient outcome both by enhancing the effect of Bortezomib (B675700) and by reducing osteoskeletal events.

5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate 준비 용품 및 원자재

원자재

준비 용품


5-[2-(1,1-DiMethylethyl-d9)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate 공급 업체

글로벌( 8)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Chemsky (shanghai) International Co.,Ltd 021-50135380
shchemsky@sina.com China 15421 60

Copyright 2019 © ChemicalBook. All rights reserved